Low birth weight and macrosomia in Tigray, Northern Ethiopia: who are the mothers at risk?

Abstract

BackgroundInfant birth weight, which is classified into low birth weight, normal birth weight and macrosomia, is associated with short and long-term health consequences, such as neonatal mortality and chronic disease in life. Macrosomia and low birth weight are double burden problems in developing counties, such as Ethiopia, but the paucity of evidence has made it difficult to assess the extent of this situation. As a result there has been inconsistency in the reported prevalence of low birth weight and macrosomia in Ethiopia. This study aimed to determine the incidence and predictors of low birth weight and macrosomia in Tigray, Northern Ethiopia.MethodWe conducted a cross-sectional survey among a cohort of 1152 neonates delivered in Tigray Region at randomly selected hospitals between April and July 2014. We used the birth weight category described previously as an outcome variable. Data were collected using structured questionnaire by midwives. We entered and analyzed data using STATA™ Version 11.0. Data were described using a frequency, percentage, relative risk ratio, and 95% confidence interval. Multinomial logistic regression was conducted to identify independent predictors of low birth weight and macrosomia.ResultIn this study, we found a 10.5% and 6.68% incidence of low birth weight and macrosomia, respectively. Seventy (57.8%) of all low birth weight neonates were term births. The predictors for low birth weight were: early marriage (<18 year) (RRR: 0.59, CI: 0.35–0.97); rural residence (RRR: 0.53, CI: 0.32–0.9); prematurity (RRR: 15.4, CI: 9.18–25.9); no antenatal follow-up (RRR: 6.78, CI: 2.39–19.25); and female sex (RRR: 1.77, CI: 1.13–2.77). Predictors for macrosomia were: female gender (RRR: 0.58, CI: 0.35–0.9); high body mass index (RRR: 5.0, CI: 1.56–16); post-maturity (RRR: 2.23, CI: 1.06–4.6); and no maternal complication (RRR: 0.46, CI: 0.27–0.8).ConclusionIn this study, we found gestational age and gender of the neonate to be common risk factors for both low birth weight and macrosomia. Strengthening antenatal follow up, prevention of pre and post maturity, controlling body mass index, and improving socioeconomic status of mothers are recommendations to prevent the double burden (low birth weight and macrosomia) and associated short and long-term consequences.

Comparing the risk of adverse pregnancy outcomes of Chinese patients with polycystic ovary syndrome with and without antiandrogenic pretreatment

“…, and macrosomia. This diagnosis was made according to the World Health Organization, which classifies infants as LBW (<2,500 g), normal birth weight (2,500-4,000), and macrosomia (R4,000 g) (22).…”

Low birth weight in Jordan: a hospital-based study

“…Worldwide, more than 20 million LBW babies (15.5% of total births) are born every year, with around 95% from developing countries [4][5][6]. The prevalence of LBW in developing countries is estimated to be 19%, compared to 5-7% in developed countries [6,7]. The incidence of LBW has not decreased in the last decade in Asia and Sub-Saharan Africa [8].…”

“…LBW is one of the leading causes of neonatal and infant morbidity and mortality [1,5,7,9]. It contributes to about 75% of deaths in the first week of life [4,6].…”

“…Extensive research confirms that LBW infants are at greater risk for developmental delays and increased medical care costs [4,8,10]. LBW infants experience health and learning problems of different types, which can negatively impact their physical, cognitive, and mental well-being [1,4,7]. Lifelong health problems related to LBW include adult-onset diabetes, coronary heart disease, hypertension, intellectual, physical and sensory disabilities, and psychological distress [1,4,6,11,12].…”

Gestational diabetes mellitus and macrosomia: An analysis of secondary data

“…Globally, the prevalence of macrosomia worldwide has increased over the past 2 to 3 decades. The incidence of fetal macrosomia varies greatly in various geographical regions, with a frequency range from 0.5% to 15% in 23 developing countries in Africa, Asia, and Latin America (Mengesha et al, 2017). In China, the prevalence of macrosomia increased from 6.0% in 1994 to 7.3% in 2014 (Wang et al, 2017).…”